PharmGKB summary-Reference-Cited by-同舟云学术

PharmGKB summary

Published:2011-10 Issue:10 Volume:21 Page:679-686
ISSN:1744-6872
Container-title:Pharmacogenetics and Genomics
language:en
Short-container-title:

Author:

Mikkelsen Torben S.,Thorn Caroline F.,Yang Jun J.,Ulrich Cornelia M.,French Deborah,Zaza Gianluigi,Dunnenberger Henry M.,Marsh Sharon,McLeod Howard L.,Giacomini Kathy,Becker Mara L.,Gaedigk Roger,Leeder James Steven,Kager Leo,Relling Mary V.,Evans William,Klein Teri E.,Altman Russ B.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Genetics (clinical),Genetics,Molecular Biology,Molecular Medicine,General Pharmacology, Toxicology and Pharmaceutics

Reference116 articles.

1. Treating childhood acute lymphoblastic leukemia without cranial irradiation.;Pui;N Engl J Med,2009

2. High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.;Widemann;Cancer,2004

3. Germ line genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects.;Trevino;J Clin Oncol,2009

4. Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia.;Buitenkamp;Haematologica,2010

5. Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis.;Tetef;Cancer Chemother Pharmacol,2000

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic polymorphisms and their association with methotrexate polyglutamates during maintenance treatment in Korean children and young adults with acute lymphoblastic leukemia;European Journal of Pharmaceutical Sciences;2024-11

2. Genetic polymorphisms and clinical parameters associated with renal toxicity in Thai hematologic malignancy patients receiving high dose methotrexate;Scientific Reports;2024-04-27

3. Enhancing the Efficacy and Safety of Methotrexate Treatment: A Focus on Drug Interactions (Review);Safety and Risk of Pharmacotherapy;2024-04-27

4. Genetic polymorphisms as predictors of methotrexate toxicity: literature review;Oncohematology;2024-04-02

5. A meta-analysis of the association between the ATIC 347 C/G polymorphism and methotrexate responsiveness and toxicity in rheumatoid arthritis;Seminars in Arthritis and Rheumatism;2024-02